The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease-Reference-Cited by-同舟云学术

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

Published:2020-10-01 Issue:6 Volume:14 Page:889-919
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Eslam Mohammed,Sarin Shiv K.,Wong Vincent Wai-Sun,Fan Jian-Gao,Kawaguchi Takumi,Ahn Sang Hoon,Zheng Ming-Hua,Shiha Gamal,Yilmaz Yusuf,Gani Rino,Alam Shahinul,Dan Yock Young,Kao Jia-Horng,Hamid Saeed,Cua Ian Homer,Chan Wah-Kheong,Payawal Diana,Tan Soek-Siam,Tanwandee Tawesak,Adams Leon A.,Kumar Manoj,Omata Masao,George Jacob

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-020-10094-2.pdf

Reference322 articles.

1. Sarin SK, Kumar M, Eslam M, George J, Al Mahtab M, Akbar SMF, Jia J, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology and hepatology Commission. Lancet GastroenterolHepatol 2020;5:167–228.

2. Wong MC, Huang JL, George J, Huang J, Leung C, Eslam M, Chan HL, et al. The changing epidemiology of liver diseases in the Asia-Pacific region. Nat Rev Gastroenterol Hepatol 2019;16:57–73.

3. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001;323:334–336.

4. Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, et al. Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2019;4:389–398.

5. Hu X, Huang Y, Bao Z, Wang Y, Shi D, Liu F, Gao Z, et al. Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterol 2012;12:123.

Cited by 533 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The myth of the stigma of fatty liver: What does the evidence show?;Annals of Hepatology;2024-11

2. Characteristics and long-term mortality of individuals with MASLD, MetALD, and ALD, and the utility of SAFE score;JHEP Reports;2024-10

3. Prevalence and impact of metabolic associated fatty liver disease in non-metastatic breast cancer women at initial diagnosis: a cross-sectional study in China;Clinical and Translational Oncology;2024-09-14

4. Significance of Phytoconstituents in Modulating Cell Signalling Pathways for the Treatment of Pancreatic Cancer;Revista Brasileira de Farmacognosia;2024-09-13

5. Biomarkers for Health Functional Foods in Metabolic Dysfunction-Associated Steatotic Liver Disorder (MASLD) Prevention: An Integrative Analysis of Network Pharmacology, Gut Microbiota, and Multi-Omics;Nutrients;2024-09-11